These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 25635653
1. Antibacterial effect of butyryl alkannin from Arnebia euchroma against vancomycin-resistant pathogens of Enterococcus faecalis causing urinary tract infections. Singh LK, Maheshwari DK, Shukla S. Nat Prod Res; 2015; 29(24):2299-301. PubMed ID: 25635653 [Abstract] [Full Text] [Related]
2. Antimicrobial activities of naphthazarins from Arnebia euchroma. Shen CC, Syu WJ, Li SY, Lin CH, Lee GH, Sun CM. J Nat Prod; 2002 Dec; 65(12):1857-62. PubMed ID: 12502328 [Abstract] [Full Text] [Related]
4. Antibacterial activity of calozeyloxanthone isolated from Calophyllum species against vancomycin-resistant Enterococci (VRE) and synergism with antibiotics. Sakagami Y, Kajimura K, Wijesinghe WM, Dharmaratne HR. Planta Med; 2002 Jun; 68(6):541-3. PubMed ID: 12094300 [Abstract] [Full Text] [Related]
5. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). Zhanel GG, Laing NM, Nichol KA, Palatnick LP, Noreddin A, Hisanaga T, Johnson JL, Hoban DJ, NAVRESS Group. J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592 [Abstract] [Full Text] [Related]
6. Influence of a subinhibitory concentration of vancomycin on the in vitro expression of virulence-related genes in the vancomycin-resistant Enterococcus faecalis. Moura TM, Campos FS, Caierão J, Franco AC, Roehe PM, d'Azevedo PA, Frazzon J, Frazzon AP. Rev Soc Bras Med Trop; 2015 Sep; 48(5):617-21. PubMed ID: 26516976 [Abstract] [Full Text] [Related]
17. [Study of marine actinomycetes isolated from the central coast of Peru and their antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis]. León J, Aponte JJ, Rojas R, Cuadra D, Ayala N, Tomás G, Guerrero M. Rev Peru Med Exp Salud Publica; 2011 Jun 03; 28(2):237-46. PubMed ID: 21845303 [Abstract] [Full Text] [Related]
19. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010). Sader HS, Moet GJ, Farrell DJ, Jones RN. Diagn Microbiol Infect Dis; 2011 Jul 03; 70(3):412-6. PubMed ID: 21546202 [Abstract] [Full Text] [Related]
20. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium. McKay GA, Beaulieu S, Arhin FF, Belley A, Sarmiento I, Parr T, Moeck G. J Antimicrob Chemother; 2009 Jun 03; 63(6):1191-9. PubMed ID: 19369269 [Abstract] [Full Text] [Related] Page: [Next] [New Search]